La catena delle opzioni mostra i dati chiave delle opzioni azionarie di Agilon Health a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per Agilon Health..

Agilon Health (NYSE:AGL) Azioni, Catena delle Opzioni

Agilon Health

Agilon Health Inc is transforming healthcare by empowering primary care physicians for the health of the patients. The company enables physicians to create their own Medicare-centric globally capitated line of business. The company derives its revenue from Medical services.

Agilon Health Inc

T2 Metals Corp

Adventure Gold - United States Dollar

AUSTRAL GOLD LTD ORD by Austral Gold Ltd.

Austral Gold Ltd

ANGELALIGN TECH INC by Angelalign Technologies Inc.

Angelalign Technology Inc

AGL Energy Ltd

AGILITY REAL EST NEW by Agility Real Estate Inc.

Agility Real Estate Inc

ANGEL TELECOM CORP by Angel Telecom Corp.

AgileThought Inc

ATLANTIS GLORY INC by Atlantis Glory Inc.

Atlantis Glory Inc

Rosenblatt analyst Blair Abernethy maintains Autodesk (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADSK#NASDAQ">ADSK</a>) with a Buy and raises the price target from $295 to $325.

News

Price Target

Analyst Ratings

ADSK

Rosenblatt Maintains Buy on Autodesk, Raises Price Target to $325

AMBA: 29% &#x7C; <a href="https://www.benzinga.com//node/42201842">Ambarella shares are trading higher after the company reported a year-over-year increase in Q3 revenue results.</a>
&nbsp;
TRNR: 86% &#x7C; <a href="https://www.benzinga.com//node/42210976">Interactive Strength Receives Letter Confirming Demonstrated Compliance With Nasdaq Listing Rule, Which Successfully Concludes Hearings Panel Appeal Process That Began In May</a>
&nbsp;
DELL: -13% &#x7C; <a href="https://www.benzinga.com//node/42201722">Dell Technologies shares are trading lower following a Q3 revenue miss.</a>

Movers

Trading Ideas

AMBA

DELL

TRNR

Market-Moving News for November 27th

Benchmark analyst Christopher Kuhn maintains Schneider National (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNDR#NYSE">SNDR</a>) with a Buy and raises the price target from $32 to $34.

SNDR

Benchmark Maintains Buy on Schneider National, Raises Price Target to $34

Legendary investor&nbsp;Warren Buffett&nbsp;has a piece of critical advice for parents that he believes they should follow, regardless of their wealth status.
What Happened: In a recent letter, the Berkshire Hathaway CEO advised parents to not just write their will but also discuss it with their children.
"Be sure each child understands both the logic for your decisions and the responsibilities they will encounter upon your death," the Oracle of Omaha said.
This, Buffett says, essentially ensures that there is clarity about the inheritance between parents and their children, reducing the chances of disputes. This is especially important when parents are no longer there to resolve differences over matters such as these.
"If any have questions or suggestions, listen carefully and adopt those found sensible. You don't want your children asking ‘Why?' in respect to
See Also:&nbsp;<a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42197276/anthony-scaramucci-trump-win-is-the-greatest-political-comeback-in-us-history-crypto-surge-following-it-was-3-years-overdue?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Anthony Scaramucci: Trump Win Is &#8216;The Greatest Political Comeback In US History'</a>
Buffett&#8217;s letter also recounted instances where families were torn apart due to unclear testamentary directives.
He encouraged parents to invite their adult children to discuss the will, ensuring transparency and understanding.
Why It Matters: This advice from Buffett aligns with his recent actions, including&nbsp;<a href="https://www.benzinga.com/news/24/11/42177867/warren-buffett-announces-new-charitable-gifts-updates-plans-for-150b-fortune-billionaire-wants-to-help-others-given-a-very-short-straw-at-birth">announcing new charitable donations</a>&nbsp;and updates to his $150 billion fortune.
Buffett has been converting Berkshire Hathaway (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRK#NYSE">BRK</a>) (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRK#NYSE">BRK</a>) shares to make these donations, emphasizing his commitment to philanthropy.
Buffett&#8217;s family dynamics also reflect his philosophy. His daughter-in-law, Mary Buffett, once thought she would receive &#8220;free candy&#8221; upon marrying his son, but learned there was no such thing with Warren, highlighting his emphasis on self-reliance and integrity.
This perspective is consistent with his hiring philosophy, where he values&nbsp;<a href="https://www.benzinga.com/startups/24/11/41976499/warren-buffett-shares-three-key-traits-to-look-for-when-hiring-says-that-without-integrity-the-other-two-will-kill-you">integrity above all</a>&nbsp;other traits.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/social-media/24/11/42155884/economist-slams-doges-simplistic-approach-to-government-spending-questions-super-bowl-ad-criticism?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Economist Slams DOGE: Tells Elon Musk-Led Initiative To &#8216;Do Your Legal Job Well&#8217; Amid Super Bowl Ad Spending Clash</a></li>
</ul>
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Photo courtesy: Shutterstock

Personal Finance

General

Warren Buffett Says Parents Should Do This One Thing Before They Die, Whether They Are Rich Or Not

Guidance

Symbotic Cuts Q1'FY25 Revenue Outlook From $495M - $515M To $480M - $500M (Est $503.579M)

Rosenblatt analyst Catharine Trebnick maintains CrowdStrike Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRWD#NASDAQ">CRWD</a>) with a Buy and maintains $385 price target.

CRWD

Rosenblatt Maintains Buy on CrowdStrike Holdings, Maintains $385 Price Target

As a result, gross profit, income (loss) before income tax, net income (loss) and adjusted EBITDA1 were also impacted. The company estimates the total impact of correcting these errors will be to lower system revenue, system gross profit, income (loss) before income tax, and adjusted EBITDA by $30 million to $40 million for fiscal year 2024 compared to the financial results released on November 18, 2024.

Symbotic Says Identified Errors In Its Revenue Recognition Related To Cost Overruns

Contracts

CAMT

Camtek Secures $50M In Pre-Launch Orders For New Hawk Product Ahead Of February 2025 Debut

CDRO

Codere Online Luxembourg Reports Q3 Revenues Of €49.2M Up From €41M YoY; Total Cash Position Of €44.0M As Of September 30

Symbotic Reports Delay In Filing Annual Report On Form 10-K; Says It Requires Additional Time To Complete Assessment Of Financial Impacts Of Correcting An Error Related To System Revenue Recognition

HC Wainwright &amp; Co. analyst Heiko Ihle maintains Electra Battery Materials (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ELBM#NASDAQ">ELBM</a>) with a Buy and lowers the price target from $1.4 to $1.3.

ELBM

HC Wainwright & Co. Maintains Buy on Electra Battery Materials, Lowers Price Target to $1.3

LASE

Laser Photonics Says Pre-Orders Are Open For Its Soon To Be Launched CTIR-3060

Denison Mines Partners With Cosa Resources To Form Joint Ventures For Uranium Exploration In Athabasca Basin

As an Amazon Web Services (AWS) partner, Beamr brings its GPU-accelerated video solutions to the curated digital storefront, enabling customers to easily discover, purchase, and deploy offerings from trusted AWS partners.
Furthermore, Beamr Cloud is expected to become a member of the AWS ISV Accelerate program, a co-sell program for independent software vendors (ISVs) that provide software solutions that are integrated with AWS.

Beamr Imaging Says Beamr Cloud Video Service Will Be Available On AWS Marketplace Starting December 1, 2024

UBS analyst Michael Lasser upgrades Dick's Sporting Goods (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DKS#NYSE">DKS</a>) from Neutral to Buy and raises the price target from $225 to $260.

Upgrades

UBS Upgrades Dick's Sporting Goods to Buy, Raises Price Target to $260

VSAT

Viasat Announced It Has Successfully Demonstrated Direct-to-device (D2D) Satellite Connectivity In The Kingdom Of Saudi Arabia For The First Time, In Conjunction With Its Ecosystem Partners

In connection with the private placement, the Company is planning to issue an aggregate of 21,220,160 shares of common stock (or pre-funded warrants in lieu thereof), Series C warrants to purchase 21,220,160 shares of common stock and Series D warrants to purchase 21,220,160 shares of common stock. The combined purchase price for each share of common stock and accompanying Series C warrant and Series D warrant is $0.377 priced at-the-market under Nasdaq rules. The Series C warrants are exercisable upon stockholder approval, will have a term of 5 years and have an exercise price of $0.475 representing 125% of the unit price. The Series D warrants are exercisable upon stockholder approval, will have a term of 2.5 years and have an exercise price of $0.475 representing 125% of the unit price. The exercise price and number of shares of common stock issuable upon exercise of the warrants are subject to adjustment upon future dilutive issuances and stock splits, subject to a floor, as described in more detail in the Company's Current Report on Form 8-K to be filed in connection with the private placement.

Biotech

Health Care

Financing

Offerings

RNAZ

TransCode Therapeutics Entered Into A Securities Purchase Agreement With Certain Institutional Investors Of Approximately $8M

HC Wainwright &amp; Co. analyst Mike Colonnese maintains Iris Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IREN#NASDAQ">IREN</a>) with a Buy and raises the price target from $13 to $16.

IREN

HC Wainwright & Co. Maintains Buy on Iris Energy, Raises Price Target to $16

Citigroup analyst Paul Lejuez upgrades Urban Outfitters (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/URBN#NASDAQ">URBN</a>) from Neutral to Buy and raises the price target from $42 to $59.

URBN

Citigroup Upgrades Urban Outfitters to Buy, Raises Price Target to $59

WW International Announced The Appointment Of Felicia DellaFortuna As Chief Financial Officer, Effective January 1; DellaFortuna Succeeds Heather Stark, Who Will Remain With Company Through December 27

Agilon Health (AGL – Research Report) received a Hold rating and price target from JMP Securities analyst Constantine Davides today. The company's ...

JMP Securities downgrades Agilon Health (AGL) to a Hold

JMP Securities analyst Constantine Davides downgraded Agilon Health (AGL) to Market Perform from Outperform without a price target following the Q3...

Agilon Health downgraded to Market Perform from Outperform at JMP Securities

Barclays lowered the firm's price target on Agilon Health (AGL) to $2 from $5 and keeps an Underweight rating on the shares. The company's Q3 resul...

Agilon Health price target lowered to $2 from $5 at Barclays

BTIG analyst David Larsen has maintained their neutral stance on AGL stock, giving a Hold rating today. David Larsen's rating is based on several f...

Agilon Health's Q3 2024 Financial Struggles and Cost Management Challenges Justify Hold Rating

TD Cowen lowered the firm's price target on Agilon Health (AGL) to $2 from $6 and keeps a Hold rating on the shares. The firm updated its model fol...

Agilon Health price target lowered to $2 from $6 at TD Cowen

Stifel Nicolaus analyst Michael Craig Jones maintained a Hold rating on Agilon Health (AGL – Research Report) today and set a price target of $2.00...

Stifel Nicolaus Sticks to Its Hold Rating for Agilon Health (AGL)

Stifel lowered the firm's price target on Agilon Health (AGL) to $2 from $7 and keeps a Hold rating on the shares. Agilon has traded down 23% since...

Agilon Health price target lowered to $2 from $7 at Stifel

In a report released today, Jailendra Singh from Truist Financial maintained a Hold rating on Agilon Health (AGL – Research Report). The company's ...

Truist Financial Reaffirms Their Hold Rating on Agilon Health (AGL)

Wells Fargo lowered the firm's price target on Agilon Health (AGL) to $4 from $8 and keeps an Overweight rating on the shares as the firm updates M...

Agilon Health price target lowered to $4 from $8 at Wells Fargo

In a report released today, Sean Dodge from RBC Capital maintained a Buy rating on Agilon Health (AGL – Research Report), with a price target of $3...

RBC Capital Reaffirms Their Buy Rating on Agilon Health (AGL)

Legal

Press Releases

Agilon Health, Inc, B. Riley Financial, Charles River Laboratories, and Getty Images Investigation Alert: Johnson Fistel, LLP Encourages Long-Term Investors to Reach Out for More Information

agilon health to Participate at 2024 Wells Fargo Healthcare Conference

AGILON HEALTH INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of agilon health, inc. - AGL

AGILON HEALTH INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of agilon health, inc. - AGL

agilon health Sets Date to Report Third Quarter 2024 Financial Results

AGILON ALERT: Bragar Eagel & Squire, P.C. is Investigating Agilon Health, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

agilon health to Participate at 2024 Wolfe Research Healthcare Conference

agilon health Reports Third Quarter 2024 Results

agilon health Reports ACO REACH Model Results for 2023 Performance Year

GETY

RILY

Accolade

Addus HomeCare Corporation - Common Stock

Addus HomeCare

AirSculpt Technologies, Inc. - Common Stock

AirSculpt Technologies

AMN Healthcare Services

Astrana Health

Aveanna Healthcare Holdings Inc. - Common Stock

Aveanna Healthcare Hldgs

Concord Medical Services Holdings Limited American Depositary Shares (Each represents thirty (30) Class A ordinary shares)

Comments

Agilon Health

Agilon Health (AGL) Opzioni

Agilon Health (NYSE:AGL) Azioni, Catena delle Opzioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO